Cargando…

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies

Inflammatory bowel disease (IBD) is a chronic intestinal disease with painful clinical manifestations and high risks of cancerization. With no curative therapy for IBD at present, the development of effective therapeutics is highly advocated. Drug delivery systems have been extensively studied to tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peng, Gao, Caifang, Chen, Hongguo, Vong, Chi Teng, Wu, Xu, Tang, Xudong, Wang, Shengpeng, Wang, Yitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463263/ https://www.ncbi.nlm.nih.gov/pubmed/34589398 http://dx.doi.org/10.1016/j.apsb.2020.11.003

Ejemplares similares

Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
por: Gao, Caifang, et al.
Publicado: (2019)

Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis
por: Gao, Caifang, et al.
Publicado: (2022)

The key issues and development strategy of Chinese Classical Formulas pharmaceutical preparations
por: Luo, Hua, et al.
Publicado: (2021)

A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis
por: Chen, Zhejie, et al.
Publicado: (2022)

Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications
por: Tan, Dechao, et al.
Publicado: (2022)

Ginseng: A bibliometric analysis of 40-year journey of global clinical trials
por: Chen, Weijie, et al.
Publicado: (2020)

Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis
por: Chen, Shiyun, et al.
Publicado: (2021)

Engineering polyphenol-based carriers for nucleic acid delivery
por: Shui, Mingju, et al.
Publicado: (2023)

The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System
por: Chong, Cheong-Meng, et al.
Publicado: (2021)

Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review
por: Algieri, Francesca, et al.
Publicado: (2015)

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
por: Luo, Hua, et al.
Publicado: (2019)

Novel drug delivery systems for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Gastrointestinal neoplasia in patients with inflammatory bowel disease: Opportunities to enhance preventative strategies
por: Young, Edward, et al.
Publicado: (2019)

Medicinal plant-based drug delivery system for inflammatory bowel disease
por: Li, Ningcen, et al.
Publicado: (2023)

Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
por: Yue, Bei, et al.
Publicado: (2020)

Cryptotanshinone from Salvia miltiorrhiza Bunge (Danshen) inhibited inflammatory responses via TLR4/MyD88 signaling pathway
por: Li, Xin-Xing, et al.
Publicado: (2020)

Current and emerging drugs for the treatment of inflammatory bowel disease
por: Triantafillidis, John K, et al.
Publicado: (2011)

Inflammatory Bowel Disease in Asia: The Challenges and Opportunities
por: Hu, Pin-Jin
Publicado: (2015)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
por: Bretto, Elisabetta, et al.
Publicado: (2023)

Chemical components, pharmacological properties, and nanoparticulate delivery systems of Brucea javanica
por: Chen, Meiwan, et al.
Publicado: (2013)

Advances in Oral Drug Delivery Systems: Challenges and Opportunities
por: Lou, Jie, et al.
Publicado: (2023)

Quality evaluation methods of chinese medicine based on scientific supervision: recent research progress and prospects
por: Chen, Zhangmei, et al.
Publicado: (2023)

Anti-Lung-Cancer Activity and Liposome-Based Delivery Systems of β-Elemene
por: Chen, Meiwan, et al.
Publicado: (2012)

Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases
por: Zhao, Yuge, et al.
Publicado: (2020)

Coptisine Attenuates Diabetes—Associated Endothelial Dysfunction through Inhibition of Endoplasmic Reticulum Stress and Oxidative Stress
por: Zhou, Yan, et al.
Publicado: (2021)

Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease
por: Guo, Yilin, et al.
Publicado: (2018)

Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities
por: Neupane, Rabin, et al.
Publicado: (2021)

Artificial intelligence in inflammatory bowel disease: current status and opportunities
por: Li, Ji, et al.
Publicado: (2020)

Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease
por: Giannoudaki, Eirini, et al.
Publicado: (2021)

Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease
por: Dong, Yumeng, et al.
Publicado: (2022)

Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study
por: Mokry, Lauren E., et al.
Publicado: (2019)

Treatment of inflammatory bowel disease: Potential effect of NMN on intestinal barrier and gut microbiota
por: Huang, Pan, et al.
Publicado: (2022)

Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease
por: Wang, Xiaomei, et al.
Publicado: (2021)

Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
por: Yadav, Manisha, et al.
Publicado: (2020)

Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
por: Wang, Shengpeng, et al.
Publicado: (2017)

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
por: Teruel, Adrian H., et al.
Publicado: (2020)

Nanosized drug delivery strategies in osteosarcoma chemotherapy
por: Chen, Chenglong, et al.
Publicado: (2023)

Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview
por: Lopes, Sílvio André, et al.
Publicado: (2023)

Screening of the active Ingredients in Huanglian Jiedu decoction through amide bond-Immobilized magnetic nanoparticle-assisted cell membrane chromatography
por: Liao, Fengyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nqusbpqrmceoqi3gs4tstojlst